To: | Geron Corporation (rochelle.alpert@morganlewis.com) |
Subject: | U.S. Trademark Application Serial No. 88757457 - GERON - 058901.2200 |
Sent: | April 07, 2020 03:09:33 PM |
Sent As: | ecom109@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88757457
Mark: GERON
|
|
Correspondence Address: |
|
Applicant: Geron Corporation
|
|
Reference/Docket No. 058901.2200
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: April 07, 2020
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by Rochelle D. Alpert on April 7, 2020, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods and/or services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and/or services are not permitted. 37 C.F.R. §2.71(a).
The identification of services is amended to read as follows:
“Providing medical information in the field of the diagnosis and treatment of cancers and hematologic malignancies to consumers, and providing medical information in the field of prevention, screening, diagnosis and treatment to scientists, researchers and medical providers on cancers and hematologic diseases, syndromes and disorders,” in International Class 44. See TMEP §§1402.01, 1402.01(e).
/Naakwama Ankrah/
Trademark Attorney Advisor
Law Office 109
571-272-9315
naakwama.ankrah@uspto.gov